Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $40.5200 (1.25%) ($38.8400 - $41.2400) on Sat. Oct. 6, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 57 | Latest Price | $40.5200(1.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ATRA price | ATRA will decline at least -1.445% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
Resistance Level | $40.71 | 5 Day Moving Average | $40.63(-0.27%) | 10 Day Moving Average | $41.13(-1.48%) | 20 Day Moving Average | $40.71(-0.47%) | To recent high | -6.9% | To recent low | 15.6% | Market Cap | $N/A | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |